These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 23292452)
21. Aberrant promoter hypermethylation and silencing of the critical 3p21 tumour suppressor gene, RASSF1A, in Chinese oesophageal squamous cell carcinoma. Wong ML; Tao Q; Fu L; Wong KY; Qiu GH; Law FB; Tin PC; Cheung WL; Lee PY; Tang JC; Tsao GS; Lam KY; Law S; Wong J; Srivastava G Int J Oncol; 2006 Mar; 28(3):767-73. PubMed ID: 16465383 [TBL] [Abstract][Full Text] [Related]
22. Frequent epigenetic inactivation of chromosome 3p candidate tumor suppressor genes in gallbladder carcinoma. Riquelme E; Tang M; Baez S; Diaz A; Pruyas M; Wistuba II; Corvalan A Cancer Lett; 2007 May; 250(1):100-6. PubMed ID: 17084965 [TBL] [Abstract][Full Text] [Related]
23. CMTM5 exhibits tumor suppressor activity through promoter methylation in oral squamous cell carcinoma. Zhang H; Nan X; Li X; Chen Y; Zhang J; Sun L; Han W; Li T Biochem Biophys Res Commun; 2014 May; 447(2):304-10. PubMed ID: 24721428 [TBL] [Abstract][Full Text] [Related]
24. NDRG2 is a candidate tumor-suppressor for oral squamous-cell carcinoma. Furuta H; Kondo Y; Nakahata S; Hamasaki M; Sakoda S; Morishita K Biochem Biophys Res Commun; 2010 Jan; 391(4):1785-91. PubMed ID: 20045673 [TBL] [Abstract][Full Text] [Related]
25. The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21.3, is an E2F-regulated, stress-responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma. Qiu GH; Tan LK; Loh KS; Lim CY; Srivastava G; Tsai ST; Tsao SW; Tao Q Oncogene; 2004 Jun; 23(27):4793-806. PubMed ID: 15122337 [TBL] [Abstract][Full Text] [Related]
26. Down-regulation of DMBT1 gene expression in human oral squamous cell carcinoma. Imai MA; Moriya T; Imai FL; Shiiba M; Bukawa H; Yokoe H; Uzawa K; Tanzawa H Int J Mol Med; 2005 Apr; 15(4):585-9. PubMed ID: 15754018 [TBL] [Abstract][Full Text] [Related]
27. The role of p300 in the tumor progression of oral squamous cell carcinoma. Cho YA; Hong JS; Choe EJ; Yoon HJ; Hong SD; Lee JI; Hong SP J Oral Pathol Med; 2015 Mar; 44(3):185-92. PubMed ID: 25154636 [TBL] [Abstract][Full Text] [Related]
28. Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India. Basu B; Chakraborty J; Chandra A; Katarkar A; Baldevbhai JRK; Dhar Chowdhury D; Ray JG; Chaudhuri K; Chatterjee R Clin Epigenetics; 2017; 9():13. PubMed ID: 28174608 [TBL] [Abstract][Full Text] [Related]
29. [Expression, loss of heterozygosity, and methylation of GNAT1 gene in nasopharyngeal carcinoma]. Yi HM; Ren CP; Peng D; Zhou L; Li H; Yao KT Ai Zheng; 2007 Jan; 26(1):9-14. PubMed ID: 17222360 [TBL] [Abstract][Full Text] [Related]
30. Expression and promoter methylation of Wnt inhibitory factor-1 in the development of oral submucous fibrosis. Zhou S; Chen L; Mashrah M; Zhu Y; He Z; Hu Y; Xiang T; Yao Z; Guo F; Zhang C Oncol Rep; 2015 Nov; 34(5):2636-42. PubMed ID: 26352791 [TBL] [Abstract][Full Text] [Related]
31. Promoter methylation of P16, RARbeta, E-cadherin, cyclin A1 and cytoglobin in oral cancer: quantitative evaluation using pyrosequencing. Shaw RJ; Liloglou T; Rogers SN; Brown JS; Vaughan ED; Lowe D; Field JK; Risk JM Br J Cancer; 2006 Feb; 94(4):561-8. PubMed ID: 16449996 [TBL] [Abstract][Full Text] [Related]
32. DNA methylation in oral squamous cell carcinoma: molecular mechanisms and clinical implications. González-Ramírez I; García-Cuellar C; Sánchez-Pérez Y; Granados-García M Oral Dis; 2011 Nov; 17(8):771-8. PubMed ID: 21781230 [TBL] [Abstract][Full Text] [Related]
33. Alterations of 3p21.31 tumor suppressor genes in head and neck squamous cell carcinoma: Correlation with progression and prognosis. Ghosh S; Ghosh A; Maiti GP; Alam N; Roy A; Roy B; Roychoudhury S; Panda CK Int J Cancer; 2008 Dec; 123(11):2594-604. PubMed ID: 18792900 [TBL] [Abstract][Full Text] [Related]
34. Epigenetic regulation of the X-linked tumour suppressors BEX1 and LDOC1 in oral squamous cell carcinoma. Lee CH; Wong TS; Chan JY; Lu SC; Lin P; Cheng AJ; Chen YJ; Chang JS; Hsiao SH; Leu YW; Li CI; Hsiao JR; Chang JY J Pathol; 2013 Jul; 230(3):298-309. PubMed ID: 23362108 [TBL] [Abstract][Full Text] [Related]
35. p16(INK4a) promoter hypermethylation in oral scrapings of oral squamous cell carcinoma risk patients. Ruesga MT; Acha-Sagredo A; Rodríguez MJ; Aguirregaviria JI; Videgain J; Rodríguez C; de Pancorbo Mde L; Aguirre JM Cancer Lett; 2007 May; 250(1):140-5. PubMed ID: 17113222 [TBL] [Abstract][Full Text] [Related]
36. Aberrant DNA methylation of tumor-related genes in oral rinse: a noninvasive method for detection of oral squamous cell carcinoma. Nagata S; Hamada T; Yamada N; Yokoyama S; Kitamoto S; Kanmura Y; Nomura M; Kamikawa Y; Yonezawa S; Sugihara K Cancer; 2012 Sep; 118(17):4298-308. PubMed ID: 22252571 [TBL] [Abstract][Full Text] [Related]
37. Overexpression of lipocalins and pro-inflammatory chemokines and altered methylation of PTGS2 and APC2 in oral squamous cell carcinomas induced in rats by 4-nitroquinoline-1-oxide. Peng X; Li W; Johnson WD; Torres KE; McCormick DL PLoS One; 2015; 10(1):e0116285. PubMed ID: 25635769 [TBL] [Abstract][Full Text] [Related]
38. Status of reduced expression and hypermethylation of the APC tumor suppressor gene in human oral squamous cell carcinoma. Uesugi H; Uzawa K; Kawasaki K; Shimada K; Moriya T; Tada A; Shiiba M; Tanzawa H Int J Mol Med; 2005 Apr; 15(4):597-602. PubMed ID: 15754020 [TBL] [Abstract][Full Text] [Related]
39. Promotor hypermethylation of p14ARF is a key alteration for progression of oral squamous cell carcinoma. Ishida E; Nakamura M; Ikuta M; Shimada K; Matsuyoshi S; Kirita T; Konishi N Oral Oncol; 2005 Jul; 41(6):614-22. PubMed ID: 15975525 [TBL] [Abstract][Full Text] [Related]
40. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium. Lerman MI; Minna JD Cancer Res; 2000 Nov; 60(21):6116-33. PubMed ID: 11085536 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]